A National Conference will be held next Thursday 20 March, organized by AboutPharma: “ISF 2014 – How medical and scientific information is changing: state of the art and future prospects" [you see: https://www.fedaiisf.it/Start/HDefault.aspx?Newsid=8894].
Important exponents of the Italian pharmaceutical industry will participate in this conference: Dompè, Doc Generici, Chiesi, Zambon. The FIMMG Secretary of Lombardy, Fiorenzo Corti (fiorenzocorti@fimmglombardia.org).
There will also be someexperts”:
– PAOLO MARIANI, University of Milan Bicocca, Prof. of economic statistics, research on applied Business Statistics and Market Analysis. Phone: 02 6448 5822 paolo.mariani@unimib.it
– LUPI & Associates Law Firm (see: http://www.impresaediritto.com/wp-content/uploads/2012/02/2007-03_Pubblicita_del_Farmaco.pdf)
– No Pharmaceutical Representatives will be present. These people don't even know that according to Legislative Decree 219 whoever does our job is not called Scientific Medical Informer and obviously defines us as "sales force"!
The Conference seems very important to us for our future. We recall that in response to Law 219/06 and the Regulation of Scientific Information on Drugs being established, Farmindustria sponsored a similar conference, also organized by About Pharma, on 20 September 2006 in Milan at the Press Club "HOW DOES SCIENTIFIC INFORMATION CHANGE AFTER THE CONSOLIDATED TEXT AND THE REGIONAL REGULATION” (attached, particularly interesting, the report by Drei) which outlined the future scenario of the pharmaceutical market and the change to be imposed on scientific information in the following years. The Union was asleep or perhaps too busy studying the transformation of the ISF in a commercial sense, in order to be able to protect it better, it did not realize that in that congress there was the declaration of everything they would have done to distort the market and lay off that huge mass of ISF, first of all the disappearance or drastic reduction of primary care. We ourselves took the matter lightly and did not evaluate the tragic consequences of that conference. We have the impression that this time we want to make the decisive commercial breakthrough for our business. Is scientific information finished? Let's hope we're wrong.
